t-cell

Documents about t-cell

• Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation#257729HAL (France)
• Investigating the Immune Response to Glioblastoma in Unique Central Nervous System Niches#273835Harvard DASH
• Transcription factor T-bet regulates the maintenance and differentiation potential of lymph node and lung effector memory B cell subsets.#298816NCBI PubMed Central
• Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia#303749ClinicalTrials.gov
• A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma#366611ClinicalTrials.gov
• Breast Cancer Cell-Derived Exosomal miR-92b-3p Promotes Tumor Angiogenesis and Metastasis by Suppressing PTEN in Vascular Endothelial Cells.#402821NCBI PubMed Central
• MDI1228, a topical pan-JAK inhibitor, disrupts dermal fibroblast-T cell chemokine crosstalk to resolve allergic contact and atopic dermatitis.#427733NCBI PubMed Central
• Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy#485313Europe PMC
• An Open-label Study of GC012F in Rheumatoid Arthritis.#836608ClinicalTrials.gov
• Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia#837447ClinicalTrials.gov
• Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection#840302ClinicalTrials.gov
• Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant#831445ClinicalTrials.gov
• GD2-CAR T Cells for Pediatric Brain Tumours#801382ClinicalTrials.gov
• CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial#226247ClinicalTrials.gov
• Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR#467597ClinicalTrials.gov
• Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients#838479ClinicalTrials.gov
• Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant#804661ClinicalTrials.gov
• A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma#845179ClinicalTrials.gov
• CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy#827811ClinicalTrials.gov
• The Mechanism of Gut Microbiota in Breast Cancer Based on the Bulk Transcriptome, Mendelian Randomization Analysis and Single Cell RNA Sequencing.#3753NCBI PubMed Central
• Potential of regulatory T cell-based therapies in the management of severe COVID-19#7997HAL (France)
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer#28314ClinicalTrials.gov
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer#28337ClinicalTrials.gov
• Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers#143565ClinicalTrials.gov
• Low cadmium concentrations alter B and T cell responses in Jamaican fruit bats (Artibeus jamaicensis)#152084Unpaywall
• T and B Cell Responses in Autoimmune Diseases#160277ClinicalTrials.gov
• Integrative Transcriptomics Identifies Ubiquitination-Related Genes BIRC2, COPS5, and TBK1 as Novel Biomarkers of T-Cell Dysregulation in Amyotrophic Lateral Sclerosis.#172021NCBI PubMed Central
• Amping up With PemJAK#249578ClinicalTrials.gov
• Combination therapy with a novel CD2-targeted costimulatory bispecific antibody overcomes limitations of CD3 T cell engager treatment for solid tumors.#285110NCBI PubMed Central
• CanLRHI: a multimodal pretraining model for cell death analysis in cancer pathology based on long-text representation and high-resolution images.#305091NCBI PubMed Central
• Knowledge mapping and research trends of chimeric antigen receptor T-cell immunotherapy in breast cancer: A bibliometric and visual analytics study.#305118NCBI PubMed Central
• Repurposing T‑614 for Gout: An In Silico Framework Integrating Network Pharmacology, Mendelian Randomization, and Single-Cell and Molecular Dynamics Analyses.#338555NCBI PubMed Central
• Identification of Prognostic Genes Relevant With the Nuclear Factors of Activated T Cells Based on Transcriptomics in Oral Squamous Cell Carcinoma.#385177NCBI PubMed Central
• Accurate quantification of spliced and unspliced transcripts for single-cell RNA sequencing with tidesurf#461616PLOS
• Application of a machine learning model integrating T cell subsets and clinical markers in 28-Day mortality prediction of sepsis patients.#483390NCBI PubMed Central
• Atomistic TCR-ligand interactions instruct memory T-cell differentiation 2330211#485008Europe PMC
• Scaffold-free three-dimensional culture of chronic lymphocytic leukaemia preserves B-T-cell cross-talk and enables drug response profiling.#785716NCBI PubMed Central
• GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma#827681ClinicalTrials.gov
• Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy#846491ClinicalTrials.gov
• BCMA/CD3 Bispecific Antibody as Bridging Therapy Before CAR-T Cell Infusion in RRMM#847881ClinicalTrials.gov
• Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation#467591ClinicalTrials.gov
• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)#839456ClinicalTrials.gov
• A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas#300255ClinicalTrials.gov
• Clinical characteristics, treatment options, and prognosis of subcutaneous panniculitis-like T-cell lymphoma from the SEER database.#9888PubMed
• Modelling and Allocation of Hydrogen-Fuel-Cell-Based Distributed Generation to Mitigate Electric Vehicle Charging Station Impact and Reliability Analysis on Electrical Distribution Systems#16667Semantic Scholar
• Multidimensional single-cell analysis of the molecular characteristics and functional pathways of Regulatory T cells in the microenvironment of HR+ breast cancer.#227876NCBI PubMed Central
• TockyLocus: quantitative analysis of flow cytometric fluorescent timer data in Nr4a3-Tocky and Foxp3-Tocky mice#251986Spiral
• Modified Guilu Erxian Glue restores immune tolerance in aplastic anemia by reprogramming T cell differentiation via the miR-146a/STAT1/SOCS1 axis.#281154NCBI PubMed Central
• Data Management and Sharing Plan for: Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs#282026UNC Dataverse Dataverse OAI Archive
• Extracellular vesicles inherit lactate from aggregated MSCs to alleviate type 1 diabetes mellitus via H(2)S-induced CD8(+) T cell exhaustion.#288843NCBI PubMed Central